Neurofeedback for ADHD: What Does the Research Actually Say?

by Ryan HayesNeurofeedback for ADHD
Part of series: Neurofeedback (Part 3)
man covering face with both hands while sitting on bench

If you search online for neurofeedback for ADHD, you’ll encounter dramatically different claims.

Some websites describe neurofeedback as a powerful alternative to medication.

Others say the evidence doesn’t support it at all.

So which is true?

The most accurate answer right now is:

There is legitimate and encouraging research on neurofeedback for ADHD—but the overall evidence remains mixed, and neurofeedback should not be presented as a proven replacement for established ADHD treatments.

I think that distinction matters.

I’m interested in neurofeedback precisely because there are promising findings around attention and self-regulation. But being interested in an emerging intervention doesn’t require overstating what we know.

So let’s look at the research.

Why would neurofeedback potentially help ADHD?

ADHD involves difficulties with attention regulation, executive functioning, inhibition, and—in many people—regulation of arousal and activity.

Neurofeedback uses EEG-based information about brain activity to provide real-time feedback while a person trains.

Rather than simply telling someone:

“Try harder to focus,”

the goal is to provide repeated opportunities for the brain to practice particular patterns of regulation.

That basic idea has led researchers to study neurofeedback for ADHD for several decades.

And some of those studies have produced genuinely encouraging results.

One influential randomized trial: Gevensleben and colleagues

In 2009, researchers studied 102 children ages 8–12 with ADHD.

Children were randomly assigned to either neurofeedback or computerized attention-skills training. The neurofeedback group completed 36 training sessions using theta/beta and slow cortical potential protocols.

The researchers found greater reductions in ADHD symptoms in the neurofeedback group than in the computerized attention-training group and concluded that the effects were clinically meaningful.

Researchers later followed participants for six months.

Among those included in the follow-up analysis, improvements in the neurofeedback group remained greater than those in the attention-training group, with a medium effect reported for the primary ADHD symptom measure.

That’s an encouraging finding.

But—as we’ll see shortly—the type of control group and who is rating improvement become very important when evaluating neurofeedback research.

How does neurofeedback compare with medication?

This question understandably gets a lot of attention.

A 2012 randomized study of 130 children and adolescents with ADHD compared neurofeedback, methylphenidate, and a combination of the two.

Based on parent reports, all three groups improved, and the researchers found neurofeedback produced significant improvements in core ADHD symptoms. They described those improvements as comparable with methylphenidate on the parent-rated outcomes they measured.

That finding is interesting.

But I would not translate it into “neurofeedback works as well as ADHD medication.”

One study using particular protocols and parent-reported outcomes isn’t sufficient to establish equivalence between neurofeedback and stimulant medication across the broader ADHD population.

Other randomized comparisons have also produced more complicated findings when neurofeedback is compared with medication and active control interventions.

This is why I don’t encourage people to frame the decision as:

medication OR neurofeedback.

The better question is:

What combination of evidence-based supports makes sense for this particular person?

What about longer-lasting changes?

One of the most interesting questions about neurofeedback is whether training effects might persist after sessions stop.

A 2014 study published in Pediatrics followed 104 children with ADHD who had been randomized to neurofeedback, computerized cognitive training, or a control condition.

At six-month follow-up, the neurofeedback group maintained greater improvements on several parent-rated ADHD and executive-function measures than the comparison groups.

Interestingly, stimulant medication dosage remained stable in the neurofeedback group while increasing in the other groups during follow-up.

Again, that’s encouraging.

It suggests the possibility that some skills developed during neurofeedback training may persist.

But it doesn’t settle the larger scientific question.

So why is the evidence still considered mixed?

This is where neurofeedback research gets particularly interesting.

Studying neurofeedback well is difficult.

Imagine that a child completes 30–40 sessions with a clinician, practices controlling something on a computer, receives encouragement, develops expectations about improvement, and gets repeated structured attention.

If symptoms improve, how much improvement came specifically from changing brain activity through neurofeedback?

That’s why stronger studies attempt to use blinded ratings, active comparison groups, or sham neurofeedback.

And when researchers apply those stricter standards, the results become less impressive.

What did the large recent meta-analysis find?

A major systematic review and meta-analysis published in JAMA Psychiatry in 2025 examined 38 randomized clinical trials involving 2,472 participants with ADHD.

The researchers focused particularly on outcomes rated by people who were probably or certainly unaware of which treatment participants received.

On those probably blinded ratings, neurofeedback did not significantly improve overall ADHD symptoms across the full group of studies.

However, there was an interesting qualification.

When researchers restricted the analysis to trials using established standard neurofeedback protocols, they found a small statistically significant improvement.

Across neuropsychological outcomes, a small improvement was also found for processing speed, while most other measured cognitive outcomes did not show significant benefits.

The authors therefore concluded that neurofeedback did not demonstrate meaningful overall benefit for ADHD at the group level, while suggesting future research should investigate whether particular protocols or particular individuals may benefit.

That’s important evidence, and I don’t think neurofeedback providers should ignore it.

But another systematic review reached a somewhat different conclusion

Science is rarely as tidy as we’d like.

A recent systematic review of ADHD treatments published in Pediatrics identified 21 neurofeedback studies.

Across the studies they analyzed, neurofeedback was associated with improvement in ADHD symptoms, including when the analysis was restricted to randomized trials.

However, the authors rated the strength of evidence as low, and neurofeedback did not consistently improve functional impairment or disruptive behavior.

So we currently have reputable researchers looking at overlapping evidence and reaching somewhat different interpretations.

That’s exactly why statements such as:

“Science has proven neurofeedback treats ADHD.”

go too far.

But so does:

“There is no evidence that neurofeedback can help ADHD.”

Neither accurately describes the literature.

What happened in the large double-blind study?

There’s another study worth knowing about because it illustrates the difficulty particularly well.

Researchers conducted a rigorous double-blind randomized trial involving 142 children ages 7–10 with ADHD.

Children received either theta/beta neurofeedback or a control treatment designed to look and feel essentially identical.

At a long-term follow-up approximately 25 months later, both groups had improved substantially—but the neurofeedback group wasn’t significantly better than the control group on the primary outcome.

That’s fascinating.

It tells us that improvement during neurofeedback studies doesn’t automatically prove that the specific EEG feedback produced the improvement.

Expectancy, practice, structure, engagement, maturation, therapeutic attention, and other nonspecific factors can matter.

Good research has to separate those effects.

Does that mean neurofeedback doesn’t work?

I wouldn’t draw that conclusion either.

Instead, I think the current evidence suggests something more nuanced:

Some people appear to improve substantially during neurofeedback.

Several randomized studies have reported meaningful ADHD symptom improvements.

Some improvements have persisted months after training ended.

But rigorous blinded studies have not consistently demonstrated that neurofeedback itself produces clinically meaningful improvements beyond comparison conditions.

And:

protocol appears to matter.

That last point is particularly interesting to me.

ADHD isn’t one identical brain pattern occurring in every person. People who carry the same diagnosis can have remarkably different nervous systems, strengths, challenges, environments, histories, sleep patterns, emotional experiences, and executive-function profiles.

The future of neurofeedback may therefore depend less on asking:

“Does neurofeedback work for ADHD?”

and more on asking:

“Which forms of neurofeedback are useful for which people, for which difficulties, under which circumstances?”

What about at-home neurofeedback?

This is especially relevant to my practice because I use a clinician-guided at-home neurofeedback model.

Portable EEG neurofeedback is a newer area of research than traditional clinic-based neurofeedback.

A recent meta-analysis specifically examining portable EEG-based neurofeedback for children with ADHD reported improvements in core ADHD symptoms compared with control groups across the included studies.

That’s encouraging, particularly as home systems become more sophisticated.

But the evidence base is still developing, and portable systems should not simply be assumed to be equivalent to every clinical neurofeedback system or every research protocol.

That’s why I prefer the phrase:

promising and worth studying

rather than:

proven solution.

If you’d like to understand how I actually structure home training, read At-Home Neurofeedback in Lubbock: How It Works and Who It May Help.

How I think about neurofeedback for ADHD

My clinical interest isn’t simply:

Can we make an ADHD score go down?

I’m interested in what a person actually experiences.

Can you direct your attention when you choose to?

Can you transition between tasks?

Can your brain settle when stimulation stops?

Can you notice distraction and return?

Can you recover after becoming overwhelmed?

Can you organize yourself enough to do what matters to you?

Can you move between activation and rest more flexibly?

Those are real-life capacities.

Neurofeedback may be one way of helping the brain practice some aspects of regulation.

But I don’t want the machine to become the entire treatment philosophy.

Neurofeedback doesn’t have to compete with medication

I think this deserves its own section.

Some families seek neurofeedback because they don’t want medication.

Others use neurofeedback alongside medication.

Others have tried medication and experienced side effects or insufficient benefit.

Still others are doing very well with medication and simply want additional support.

I don’t believe someone needs to become ideologically “pro-medication” or “anti-medication” to make a thoughtful decision.

Medication decisions should be made with an appropriate medical prescriber.

My role is different.

I can help someone explore whether neurofeedback, psychological work, nervous-system regulation, behavioral strategies, and practical integration might provide additional support.

Why I combine neurofeedback with integration

This is probably the part of the research conversation that most influences my own approach.

Even if we help a brain become more flexible, a person still has to live differently with that capacity.

Attention happens at school.

At work.

During homework.

In conversations.

While parenting.

While trying to sleep.

While responding to stress.

So I don’t think the most interesting question is simply:

“Did your neurofeedback score improve?”

I want to know:

“What can you do now that was difficult before?”

That’s why my neurofeedback approach includes attention to the whole person and practical integration alongside brain training.

I explain that philosophy more fully in Why I Pair Neurofeedback With Integration: A Whole-Person Approach to Brain Training.

Should I try neurofeedback for ADHD?

There isn’t a universal answer.

If you or your child has ADHD, neurofeedback may be an option worth discussing—particularly if you’re interested in brain-based training as one part of a broader approach.

But I would be cautious of anyone promising that neurofeedback will “cure ADHD,” permanently normalize the brain, or universally replace medication.

The research simply doesn’t justify those claims.

What it does justify, in my opinion, is continued curiosity.

There is enough encouraging evidence to make neurofeedback genuinely interesting.

And enough conflicting evidence to require humility.

That’s the posture I want to bring to the work: curious, evidence-informed, individualized, and focused on whether meaningful changes are actually occurring in someone’s life.

Neurofeedback for ADHD in Lubbock, Texas

I offer clinician-guided at-home neurofeedback through Ryan Hayes Therapy in Lubbock.

The process combines assessment, individualized neurofeedback training, home practice, ongoing monitoring, and integration support.

You can learn about the program, assessment process, and current pricing on my Neurofeedback page.

If you’re wondering whether neurofeedback might make sense for you or your child, you can also:

Schedule a free 15-minute call with Ryan

You don’t need to decide whether neurofeedback is “good” or “bad.” We can start with a much simpler question:

What are you hoping will change, and does this seem like a reasonable tool to explore?

Frequently Asked Questions

Does research show that neurofeedback works for ADHD?

Research is mixed. Several randomized studies have reported improvements in ADHD symptoms following neurofeedback, while rigorous blinded trials and a recent large meta-analysis have found much smaller or nonsignificant effects. Evidence suggests that protocol, study design, and individual differences may matter considerably.

Is neurofeedback as effective as ADHD medication?

Some individual studies have reported comparable improvements on certain parent-rated outcomes, but the overall evidence does not establish neurofeedback as equivalent to stimulant medication. Neurofeedback should therefore not be presented as a proven replacement for medication.

Can neurofeedback replace ADHD medication?

Possibly for some individuals as part of an individualized plan, but the research does not support recommending neurofeedback as a universal substitute for medication. Medication decisions should be discussed with an appropriate medical professional.

Are neurofeedback improvements permanent?

Some studies have reported sustained improvements several months after training, but long-term outcomes vary and the evidence isn’t sufficient to promise permanent changes.

Is at-home neurofeedback effective for ADHD?

Research specifically examining portable EEG-based neurofeedback is developing, with some encouraging findings, but the evidence base is smaller than that for neurofeedback overall. More rigorous research is needed.

Research referenced